SOUTHERN JOURNAL OF SCIENCES

Diabetes mellitus (DM) is a clinical disease correlated with a deficiency of insulin secretion or action.It is one of the leading causes of morbidity and mortality worldwide. The global burden of diabetes is rising dueto increasing obesity and population aging. Urinary tract infections (UTI) are common microbial infections knownto affect the different parts of the urinary tract accounting for major antibacterial drug consumption. About 150million UTI cases were diagnosed every year. Urinary tract infections are the most important and most commonsite of infections in a diabetic patient. Diabetic patients have been found to have a 5-fold frequency of acutepyelonephritis at autopsy than non-diabetics. Most of the urinary tract infections in patients with diabetes arerelatively asymptomatic. The presence of this syndrome predisposes to much more severe infections,particularly in patients with acute ketoacidosis, poor diabetic control, diabetic complications such as neuropathy,vasculopathy, and nephropathy. The Gram-negative aerobic bacilli are the large group of bacterial pathogensthat cause UTI with few species of Gram-positive bacteria. However, some fungi, parasites, and viruses havealso been reported to invade the urinary tract. Urinary tract infection affects women more than men due toseveral factors such as proximity of the genital tract to the urethra, anatomy of the female urethra, sexualactivity, menopause, and pregnancy. Other possible risk factors of UTI include allergy, obesity, diabetes, pasthistory of UTI, contraceptive use, catheter use, and family history. 

Background: This interview covers Dr. Peter McCullough’s medical career, experience as an editor of medical journals, and his expertise in areas such as cardiomyopathy, myocarditis, and pericarditis. Aims: The primary aim is to understand Dr. McCullough’s perspectives on various medical topics, including his journey as a cardiologist, the importance of peer review, the phenomenon of Pheidippides cardiomyopathy, the differences between myocarditis and pericarditis, and the significance of ethical principles like the Nuremberg Code and the Declaration of Helsinki. Additionally, the interview aims to explore his concerns about censorship during the COVID-19 pandemic. Methods: The interview follows a question-and-answer format, with the interviewer posing questions to Dr. McCullough on various topics related to his medical career, research interests, and ethical considerations. Results: Dr. McCullough shares his insights on topics such as cardiomyopathy, myocarditis, and pericarditis, emphasizing the importance of peer review, identifying potential biases, and balancing scientific rigor with timely dissemination of findings. He also highlights the significance of the Nuremberg Code and the Declaration of Helsinki in ensuring informed consent and preventing coercion in medical research and treatment. Discussion: Dr. McCullough expresses concerns about censorship during the COVID-19 pandemic, which he believes impacted the ability of medical professionals to freely discuss and disseminate health-related information. He also discusses the potential role of COVID-19 vaccines in causing myocarditis and the need for transparent communication about treatment options and potential complications. Conclusion: The interview provides valuable insights from Dr. McCullough’s extensive medical experience and expertise, covering a range of topics from cardiovascular conditions to ethical principles and the challenges posed by censorship during the COVID-19 pandemic.

Background: A crucial aspect of electrochemical enzymatic biosensor development is the immobilization of the enzymes, as it directly influences the sensitivity of the bioelectrode. Among the different methods used to incorporate enzymes on the surface of the transducers, layer-by-layer (LbL) self-assembly based on electrostatic interaction with polyelectrolytes of opposite charge stands out due to its simplicity and reproducibility. Aims: The aim of the work was to develop an electrochemical glucose biosensor by LbL assembly of a new functionalized chitosan polycation and the enzyme glucose oxidase (GOx). Methods: Chitosan was chemically functionalized with glucose by the Maillard reaction. The resulting polycation, named G-Chit, is soluble in the medium compatible with the enzyme. The bioelectrode was obtained by alternating adsorption of G-Chit and GOx onto carbon paste electrodes. By selecting the number of bilayer of G-Chit/GOX, the enzyme concentration, and the pH, the electroanalytical performance of the biosensor was optimized. The electrochemical responses were characterized by cyclic voltammetry and chronoamperometry. Results: Under optimized experimental conditions, the biosensor exhibited a sensitivity of (0.81 ± 0.03) µA mM-1 in a glucose concentration range of (0.18 to 1.75) mM. Discussion: Results indicated that catalytic response increases both with the number of G-Chit/GOx bilayers and the enzyme concentration, obtaining the best responses for 3 bilayers and 2 mg mL-1, respectively, while the optimum working pH value was 7.0. Conclusions: The analytical response of the biosensor was tested in milk samples with negligible matrix effects, suggesting a potential application in other dairy products. Results show that G-Chit appears promising for the immobilization of enzymes.